Eyenovia Inc.

4.98-0.0600-1.19%Vol 55.78K1Y Perf 66.03%
Apr 19th, 2021 15:14 DELAYED
BID4.97 ASK5.00
Open5.00 Previous Close5.05
Pre-Market- After-Market-
 - -%  - -
Target Price
12.50 
Analyst Rating
Strong Buy 1.00
Potential %
150.50 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/100/100 
Value Ranking
★★ —    48.04
Insiders Value % 3/6/12 mo.
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/100/100 
Income Ranking
 —    -
Market Cap127.61M 
Earnings Rating
Buy
Price Range Ratio 52W %
47.00 
Earnings Date
12th May 2021

Today's Price Range

4.855.13

52W Range

2.557.72

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-12.35%
1 Month
-20.63%
3 Months
-23.17%
6 Months
34.40%
1 Year
66.03%
3 Years
-42.20%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
EYEN4.98-0.0600-1.19
AAPL134.330.17000.13
GOOG2 297.58-0.1800-0.01
MSFT258.47-2.2700-0.87
XOM56.17-0.4900-0.86
WFC43.970.13000.30
JNJ162.580.34000.21
FB301.01-5.1700-1.69
GE13.420.03000.22
JPM152.75-0.5500-0.36
Financial StrengthValueIndustryS&P 500US Markets
1.70
1.80
0.02
0.03
-1 159.10
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
60.00
-210.20
-209.10
-
-
RevenueValueIndustryS&P 500US Markets
2.00M
0.08
-
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.21-0.1719.05
Q03 2020-0.14-0.23-64.29
Q02 2020-0.21-0.25-19.05
Q01 2020-0.31-0.310.00
Q04 2019-0.32-0.313.12
Q03 2019-0.36-0.2919.44
Q02 2019-0.47-0.446.38
Q01 2019-0.51-0.501.96
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.220.00-
6/2021 QR-0.220.00-
12/2021 FY-0.847.69Positive
12/2022 FY-0.69-1.47Negative
Next Report Date12th May 2021
Estimated EPS Next Report-0.22
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume55.78K
Shares Outstanding25.62M
Trades Count263
Dollar Volume821.26K
Avg. Volume155.79K
Avg. Weekly Volume81.23K
Avg. Monthly Volume109.26K
Avg. Quarterly Volume134.63K

Eyenovia Inc. (NASDAQ: EYEN) stock closed at 5.04 per share at the end of the most recent trading day (a -6.32% change compared to the prior day closing price) with a volume of 66.76K shares and market capitalization of 127.61M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 29 people. Eyenovia Inc. CEO is Tsontcho Ianchulev.

The one-year performance of Eyenovia Inc. stock is 66.03%, while year-to-date (YTD) performance is -16.83%. EYEN stock has a five-year performance of %. Its 52-week range is between 2.55 and 7.72, which gives EYEN stock a 52-week price range ratio of 47.00%

Eyenovia Inc. currently has a PE ratio of -6.10, a price-to-book (PB) ratio of 9.63, a price-to-sale (PS) ratio of 68.67, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -81.35%, a ROC of -115.36% and a ROE of -146.20%. The company’s profit margin is -%, its EBITDA margin is -209.10%, and its revenue ttm is $2.00 Million , which makes it $0.08 revenue per share.

Of the last four earnings reports from Eyenovia Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.22 for the next earnings report. Eyenovia Inc.’s next earnings report date is 12th May 2021.

The consensus rating of Wall Street analysts for Eyenovia Inc. is Strong Buy (1), with a target price of $12.5, which is +150.50% compared to the current price. The earnings rating for Eyenovia Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Eyenovia Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Eyenovia Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.61, ATR14 : 0.49, CCI20 : -109.48, Chaikin Money Flow : -0.18, MACD : -0.30, Money Flow Index : 41.73, ROC : -2.33, RSI : 39.18, STOCH (14,3) : 4.88, STOCH RSI : 0.12, UO : 46.32, Williams %R : -95.12), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Eyenovia Inc. in the last 12-months were: Ernest Mario (Option Excercise at a value of $93 560), Jennifer Clasby (Option Excercise at a value of $52 137), John P. Gandolfo (Buy at a value of $13 600), Tsontcho Ianchulev (Option Excercise at a value of $93 560)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.50
Strong Buy
1.50

Eyenovia Inc.

Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.

CEO: Tsontcho Ianchulev

Telephone: +1 917 289-1117

Address: 295 Madison Avenue, New York 10017, NY, US

Number of employees: 29

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits